Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Eskayef
FDA Approves PREGABALIN — Eskayef Pharmaceuticals Limited

# FDA Approves Pregabalin Generic from Eskayef Pharmaceuticals Eskayef Pharmaceuticals Limited received FDA approval for its generic pregabalin oral ...

Sobi,
FDA Approves VONJO — Sobi, Inc.

Sobi, Inc. received FDA approval for VONJO (pacritinib) to treat adult patients with Philadelphia-negative myelofibrosis who have intolerant or refrac...

BluePoint
FDA Approves DIVALPROEX SODIUM — BluePoint Laboratories

# FDA Approves Generic Divalproex Sodium for BluePoint Laboratories BluePoint Laboratories has received FDA approval for its generic divalproex sodiu...

Amneal
FDA Approves RELEUKO — Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals announced the FDA approval of its intravenousfilgrastim injection under the brand name RELEUKO, positioning the company to expa...

ScieGen
FDA Approves METFORMIN HYDROCHLORIDE — ScieGen Pharmaceuticals, Inc.

ScieGen Pharmaceuticals, Inc. secured approval for generic Metformin HCl Extended-Release Tablets, addressing a significant portion of the massive Typ...

INGENUS
FDA Approves Unknown Drug — INGENUS PHARMS NJ

INGENUS PHARMS is expected to see a positive impact on its consolidated sales following the receipt of FDA approval for its generic equivalent under A...

Apotex
FDA Approves BRIMONIDINE TARTRATE — Apotex Corp.

# FDA Approves Apotex's Generic Brimonidine Tartrate Ophthalmic Treatment Apotex Corp. received FDA approval for its generic brimonidine tartrate oph...

Genentech,
FDA Approves VABYSMO — Genentech, Inc.

# FDA Approves Genentech's VABYSMO for Retinal Disease Treatment Genentech has received FDA approval for VABYSMO (faricimab), a novel intravitreal in...

Sandoz
FDA Approves TAFLUPROST — Sandoz Inc

Sandoz Inc. received FDA approval to market the generic version of tafluprost (ANDA 209040) on Jan. 28, 2022, introducing a new low-cost option to the...

MYLAN
FDA Approves Unknown Drug — MYLAN

# FDA Approval Newswire Mylan received FDA approval for a generic drug application (ANDA210275) on January 26, 2022, positioning the company to captu...

Hikma
FDA Approves BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. received FDA approval for a new generic of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate, raising potentia...

TEVA
FDA Approves Unknown Drug — TEVA PHARMS USA

On January 25, 2022, Teva Pharmaceuticals received FDA approval for ANDA211272, a move which, while filling a specific regulatory void, does not curre...

Zydus
FDA Approves VIGABATRIN — Zydus Pharmaceuticals (USA) Inc.

# FDA Approves Generic Vigabatrin The FDA has approved Zydus Pharmaceuticals' generic version of vigabatrin, an oral antiepileptic medication, potent...

U.S.
FDA Approves CIBINQO — U.S. Pharmaceuticals

New York, January 14, 2022 – U.S. Pharmaceuticals announced today the FDA approval of CIBINQO (abrocitinib), a novel oral therapy for chronic urticari...

Alembic
FDA Approves DOXYCYCLINE HYCLATE — Alembic Pharmaceuticals Limited

# FDA Approves Alembic Pharmaceuticals' Doxycycline Hyclate Generic Alembic Pharmaceuticals Limited has received FDA approval for its generic doxycyc...

Cranbury
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Cranbury Pharmaceuticals, LLC

Cranbury Pharmaceuticals, LLC won FDA approval for its ANDA201295 generic of Hydrocodone Bitartrate and Acetaminophen, marking the company's entry int...

Novartis
FDA Approves LEQVIO — Novartis Pharmaceuticals Corporation

# FDA Approves Novartis's LEQVIO (Inclisiran) for Cholesterol Management The FDA has approved Novartis Pharmaceuticals Corporation's LEQVIO (inclisir...

PHARMOBEDIENT
FDA Approves Unknown Drug — PHARMOBEDIENT

# FDA Approves New Generic Drug Application for PharmObedient The FDA has approved ANDA 208120 for PharmObedient, expanding the manufacturer's generi...

Janssen
FDA Approves XARELTO — Janssen Pharmaceuticals, Inc.

# FDA Approves New Oral Formulation of Janssen's XARELTO (Rivaroxaban) The U.S. Food and Drug Administration has approved Janssen Pharmaceuticals' XA...

argenx
FDA Approves VYVGART — argenx US

# FDA Approves argenx's VYVGART for Myasthenia Gravis argenx US received FDA approval for VYVGART (efgartigimod alfa), a novel intravenous immunoglob...